Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Purohit VS"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bauman JN; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.) jonathan.bauman@pfizer.com., Doran AC; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Gualtieri GM; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Hee B; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Strelevitz T; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Cerny MA; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Banfield C; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Plotka A; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Wang X; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Purohit VS; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Dowty ME; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.).
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2024 Sep 16; Vol. 52 (10), pp. 1124-1136. Date of Electronic Publication: 2024 Sep 16.
Autor:
Maleki F; Clinical Pharmacology & Pharmacometrics, Global Product Development, Pfizer, Cambridge, MA, 02139, USA. farzanmaleki83@gmail.com., Chang C; Clinical Pharmacology & Pharmacometrics, Global Product Development, Pfizer, Cambridge, MA, 02139, USA., Purohit VS; Clinical Pharmacology & Pharmacometrics, Global Product Development, Pfizer, Cambridge, MA, 02139, USA., Nicholas T; Clinical Pharmacology & Pharmacometrics, Global Product Development, Pfizer, Cambridge, MA, 02139, USA.
Publikováno v:
Pharmaceutical research [Pharm Res] 2024 Apr; Vol. 41 (4), pp. 623-636. Date of Electronic Publication: 2024 Mar 22.
Autor:
Huh Y; Worldwide Development, Research and Medical, Pfizer Inc, 280 Shennecossett Rd, Groton, CT, 06340, USA. yeamin.huh@pfizer.com., Wojciechowski J; Worldwide Development, Research and Medical, Pfizer Inc, 280 Shennecossett Rd, Groton, CT, 06340, USA., Purohit VS; Worldwide Development, Research and Medical, Pfizer Inc, 280 Shennecossett Rd, Groton, CT, 06340, USA.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2024 Mar; Vol. 63 (3), pp. 381-394. Date of Electronic Publication: 2024 Feb 15.
Autor:
Huh Y; Pfizer Inc, Groton, CT, USA. YeaMin.Huh@pfizer.com., Plotka A; Pfizer Inc, Collegeville, PA, USA., Wei H; Pfizer Inc, Shanghai, China., Kaplan J; Pfizer Inc, Groton, CT, USA., Raha N; Pfizer Inc, Groton, CT, USA., Towner J; Pfizer Inc, Groton, CT, USA., Purohit VS; Pfizer Inc, Groton, CT, USA., Dowty ME; Pfizer Inc, Cambridge, MA, USA., Wolk R; Pfizer Inc, Groton, CT, USA., Vourvahis M; Pfizer Inc, New York, NY, USA., King-Ahmad A; Pfizer Inc, Groton, CT, USA., Mathialagan S; Pfizer Inc, Groton, CT, USA., West MA; Pfizer Inc, Groton, CT, USA., Lazzaro S; Pfizer Inc, Groton, CT, USA., Ryu S; Pfizer Inc, Groton, CT, USA., Rodrigues AD; Pfizer Inc, Groton, CT, USA.
Publikováno v:
Pharmaceutical research [Pharm Res] 2023 Nov; Vol. 40 (11), pp. 2639-2651. Date of Electronic Publication: 2023 Aug 10.
Autor:
Liu J; Clinical Pharmacology, Pfizer Investment Co., Ltd., 9/F, Tower B, Minmetals Plaza, Dongcheng District, Beijing, 100010, China., Solan R; Pfizer Research & Development UK Limited, Hurley, UK., Wolk R; Pfizer Global Research & Development, Groton, Connecticut, USA., Plotka A; Biostatistics, Pfizer Inc., Collegeville, Pennsylvania, USA., O'Gorman MT; Clinical Pharmacology, Pfizer Inc., Groton, Connecticut, USA., Winton JA; Clinical Pharmacology, Pfizer Inc., Groton, Connecticut, USA., Kaplan J; Pfizer Inc., La Jolla, California, USA., Purohit VS; Clinical Pharmacology, Pfizer Inc., Groton, Connecticut, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2023 Jul; Vol. 89 (7), pp. 2208-2215. Date of Electronic Publication: 2023 Mar 02.
Autor:
Wojciechowski J; Pfizer Inc., Groton, Connecticut, USA., Purohit VS; Pfizer Inc., Groton, Connecticut, USA., Harnisch LO; Pfizer Ltd., Sandwich, UK., Dua P; Pfizer Ltd., Sandwich, UK., Tan B; Pfizer Inc., Cambridge, Massachusetts, USA., Nicholas T; Pfizer Inc., Groton, Connecticut, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Dec; Vol. 112 (6), pp. 1291-1302. Date of Electronic Publication: 2022 Oct 04.